Table 3.
Treatment Details and Complicationsa.
| Characteristic | % (n) of Patients |
|---|---|
| Neoadjuvant therapy, n = 179 | |
| Radiation | 15.6% (28) |
| Chemotherapy | 2.8% (5) |
| Surgical margin, n = 991 | |
| Wideb | 39.1% (387) |
| Marginalc | 21.8% (216) |
| Wide-contaminated | 1.9% (19) |
| Intralesionald | 17.2% (170) |
| Negative (not specified)e | 20.1% (199) |
| Adjuvant therapy, n = 780 | |
| Radiation | 37.1% (289) |
| Chemotherapy | 1.8% (14) |
| Complication requiring reoperation, n = 335 | 15.8% (53) |
| Wound complications, n = 552 | |
| Dehiscence | 19.2% (106) |
| Infection | 17.2% (95) |
Abbreviation: n, number of patients at risk (in studies reporting characteristic).
aOut of nearly 1000 surgeries, 81% had negative margins (39% wide, 22% marginal, 20% unspecified negative).
bReported as wide, radical, or >2 cm from tumor.
cReported as marginal or >0.01 cm and <2 cm from tumor.
dReported as intralesional, positive, inadequate, or R2.
eReported as negative, tumor-free, R0, clean, adequate, gross total, or complete.